Loading...

Soligenix Receives $840,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received approximately $840,000, net of transaction costs, in non-dilutive


source https://finance.yahoo.com/news/soligenix-receives-840-000-non-110000663.html

Comments

Popular Posts

How to create Contact form (Official) to contact page

Returning to the office is going to look different

How to create a page like About us, Contact us, Privacy Policy and Disclaimer on Blogger

Global Anomaly Detection Industry

Loading...